News

Tiziana Life Sciences Announces Purchase of Common Shares by Executive Chairman

NEW YORK, June 09, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd.(Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company…

2 years ago

Exavir Therapeutics announces publication of preclinical data for ultra-long-acting dolutegravir prodrug XVIR-120

Ultra-long-acting plasma pharmacokinetics and biodistribution to tissues of interest demonstrated in three species Injections were well tolerated with no adverse…

2 years ago

Satsuma Pharmaceuticals Announces Five Abstracts Accepted for Presentation at The American Headache Society’s 64th Annual Scientific Meeting

Oral Presentation: Initial Data from ASCEND Study Highlights STS101’s Long-Term Safety and TolerabilitySOUTH SAN FRANCISCO, Calif., June 09, 2022 (GLOBE…

2 years ago

Nova Mentis and University of Central Florida to Develop Saliva Serotonin Assay

Vancouver, British Columbia--(Newsfile Corp. - June 9, 2022) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF)…

2 years ago

Medical Device Innovation Consortium (MDIC) Announces Andrew Fish, JD Appointed as President and Chief Executive Officer (CEO)

ARLINGTON, Va.--(BUSINESS WIRE)--The Medical Device Innovation Consortium (MDIC) today announced that Andrew Fish, JD has been appointed as President and…

2 years ago

BioFuse Medical Technologies Welcomes New Member, Joseph Stauffer, DO, MBA, FAPCR to the Board of Directors

MELBOURNE, FL / ACCESSWIRE / June 8, 2022 / BioFuse Medical Technologies, Inc., an emerging surgical device company with transformative…

2 years ago

CureVac Accelerates Oncology Strategy with Acquisition of Frame Cancer Therapeutics, Adding Novel Antigen Discovery Platform

Acquisition extends CureVac's capabilities and adds key competencies to further accelerate oncology strategy for new therapies that enable patients' immune…

2 years ago

Love Pharma Inc. Announces First Closing of Financing

VANCOUVER, BC / ACCESSWIRE / June 8, 2022 / LOVE Pharma Inc. ("LOVE" and or "the Company") (CSE:LUV)(FSE:G1Q0), announces it…

2 years ago

CureVac Announces Changes of CDO – Myriam Mendila to Succeed Klaus Edvardsen

Myriam Mendila appointed as Chief Development Officer starting from February 1, 2023Klaus Edvardsen returning to Denmark after holding numerous leadership…

2 years ago

Novamind Shareholders Approve Proposed Acquisition by Numinus

Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this…

2 years ago